Rolditamig
Based on 1 Customer Validation
Rolditamig (TQB2102 Antibody) is a recombinant humanized anti-human epidermal growth factor receptor 2 (HER2) antibody. Rolditamig can be conjugated with an enzyme-cleavable linker and a topoisomerase I inhibitor to form the ADC TQB2102. Rolditamig is applicable to research on solid tumors such as HER2-positive breast cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 95.26%
- CAS 番号: 3038136-62-5
- 分子量:124.8 kDa
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
EGFR アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
Isotype
immunoglobulin (H-gamma1_L-kappa)_scFvhk-G1(h-CH2-CH3)
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
HER2 |
遺伝子ID
アクセッション番号
Target
ERBB2/HER2/CD340
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
G1-kappa_scFv-HEAVY-KAPPA-h-CH2-CH3
アプリケーション
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized HER2/CD340 Protein, Human (HEK293, HY-P73094) can bind Rolditamig, The ED50 for this effect is 3.572 ng/mL.
化学情報
-
CAS 番号 3038136-62-5
-
性状 Liquid
-
分子量 124.8 kDa
-
Color Colorless to off-white
-
SMILES
[Rolditamig]
-
別名
TQB2102 Antibody
-
輸送条件
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
純度とドキュメンテーション
-
データシート (272 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Rolditamig
- 3038136-62-5
- TQB2102 Antibody
- ADC Antibodies
- EGFR
- HER2 low metastatic breast cancer
- human epidermal growth factor receptor 2
- HER2 positive gastric cancer
- extracellular domains II
- extracellular domains IV
- HER2 3+ colorectal cancer
- advanced solid tumors
- HER2
- HER2 positive metastatic breast cancer
- Inhibitor
- inhibitor
- inhibit